Notable Reporting: After Today’s Significant Decline, Is Iradimed Corp’s Near-Term Analysis Negative?

Notable Reporting: After Today's Significant Decline, Is Iradimed Corp's Near Term Analysis Negative?

The stock of Iradimed Corp (NASDAQ:IRMD) is a huge mover today! About 72,607 shares traded hands. Iradimed Corp (NASDAQ:IRMD) has declined 27.28% since April 18, 2016 and is downtrending. It has underperformed by 31.71% the S&P500.
The move comes after 8 months negative chart setup for the $126.18M company. It was reported on Nov, 18 by Barchart.com. We have $9.31 PT which if reached, will make NASDAQ:IRMD worth $15.14 million less.

Iradimed Corp (NASDAQ:IRMD) Ratings Coverage

Out of 2 analysts covering iRadimed (NASDAQ:IRMD), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. iRadimed has been the topic of 5 analyst reports since July 30, 2015 according to StockzIntelligence Inc. Roth Capital maintained the stock with “Buy” rating in Monday, November 2 report. The rating was maintained by TH Capital on Monday, November 2 with “Buy”. As per Wednesday, October 5, the company rating was downgraded by Roth Capital. Roth Capital maintained the stock with “Buy” rating in Monday, April 4 report. TH Capital maintained the stock with “Buy” rating in Thursday, July 30 report.

According to Zacks Investment Research, “iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida.”

Insitutional Activity: The institutional sentiment increased to 1.86 in 2016 Q2. Its up 0.73, from 1.13 in 2016Q1. The ratio is positive, as 15 funds sold all Iradimed Corp shares owned while 16 reduced positions. 8 funds bought stakes while 27 increased positions. They now own 2.15 million shares or 23.57% less from 2.82 million shares in 2016Q1.
Blackrock Advisors Limited Liability Com holds 0% or 8,343 shares in its portfolio. Moreover, Spark Invest Ltd Liability Corp has 0.07% invested in Iradimed Corp (NASDAQ:IRMD) for 35,000 shares. Tiaa Cref Invest Mgmt Limited accumulated 13,484 shares or 0% of the stock. Ny State Common Retirement Fund holds 0% or 2,600 shares in its portfolio. Blackrock Investment Mgmt Ltd Liability Corporation last reported 14,741 shares in the company. Blackrock Fund Advisors accumulated 0% or 105,283 shares. Fincl Architects Inc last reported 0% of its portfolio in the stock. Timpani Mngmt Ltd holds 0.69% of its portfolio in Iradimed Corp (NASDAQ:IRMD) for 74,936 shares. Menta Ltd Company has 0.13% invested in the company for 41,919 shares. Awm Inv Co holds 158,830 shares or 0.74% of its portfolio. Globeflex Cap L P accumulated 0.22% or 37,143 shares. Vanguard Grp last reported 0% of its portfolio in the stock. Jfs Wealth Advisors Llc has 1.14% invested in the company for 190,000 shares. Northern Trust Corporation, a Illinois-based fund reported 66,463 shares. Reilly Financial Advsrs Limited Liability Company last reported 500 shares in the company.

Insider Transactions: Since June 9, 2016, the stock had 1 insider buy, and 4 insider sales for $512,086 net activity. $42,931 worth of shares were sold by ALLEN MONTY K on Thursday, June 9. $35,857 worth of shares were sold by Nardi Steven M. on Monday, August 15. Shares for $440,078 were sold by Waldman Louis S. on Wednesday, August 31. Susi Roger E. bought $52,280 worth of stock.

More notable recent Iradimed Corp (NASDAQ:IRMD) news were published by: Streetinsider.com which released: “Iradimed Corp. (IRMD) Tops Q3 EPS by 3c” on October 28, 2016, also Seekingalpha.com with their article: “iRadimed Corp. (IRMD) CEO Roger Susi on Q3 2016 Results – Earnings Call Transcript” published on October 29, 2016, Seekingalpha.com published: “IRadimed Corp. (IRMD) CEO Roger Susi on Q2 2016 Results – Earnings Call Transcript” on July 31, 2016. More interesting news about Iradimed Corp (NASDAQ:IRMD) were released by: Zacks.com and their article: “Should You Get Rid of IRadimed Corporation (IRMD) Now?” published on October 14, 2016 as well as Globenewswire.com‘s news article titled: “IRADIMED CORPORATION Announces Second Quarter 2016 Financial Results” with publication date: July 29, 2016.

IRMD Company Profile

IRADIMED CORPORATION (IRADIMED), incorporated on April 8, 2014, develops, makes, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Firm operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. The Company’s MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous parts and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. Each system consists of MRidium MRI compatible IV infusion pump, non-magnetic mobile stand and disposable IV tubing sets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Comment